193 related articles for article (PubMed ID: 35083298)
1. Sodium-Glucose Co-transporter-2 Inhibitor of Dapagliflozin Attenuates Myocardial Ischemia/Reperfusion Injury by Limiting NLRP3 Inflammasome Activation and Modulating Autophagy.
Yu YW; Que JQ; Liu S; Huang KY; Qian L; Weng YB; Rong FN; Wang L; Zhou YY; Xue YJ; Ji KT
Front Cardiovasc Med; 2021; 8():768214. PubMed ID: 35083298
[No Abstract] [Full Text] [Related]
2. Artemisinin suppresses myocardial ischemia-reperfusion injury via NLRP3 inflammasome mechanism.
Wang F; Gao Q; Yang J; Wang C; Cao J; Sun J; Fan Z; Fu L
Mol Cell Biochem; 2020 Nov; 474(1-2):171-180. PubMed ID: 32729005
[TBL] [Abstract][Full Text] [Related]
3. Scutellarin protects against myocardial ischemia-reperfusion injury by suppressing NLRP3 inflammasome activation.
Xu LJ; Chen RC; Ma XY; Zhu Y; Sun GB; Sun XB
Phytomedicine; 2020 Mar; 68():153169. PubMed ID: 31999976
[TBL] [Abstract][Full Text] [Related]
4. Shexiang Baoxin Pill attenuates myocardial ischemia/reperfusion injury by activating autophagy via modulating the ceRNA-Map3k8 pathway.
Yu YW; Liu S; Zhou YY; Huang KY; Wu BS; Lin ZH; Zhu CX; Xue YJ; Ji KT
Phytomedicine; 2022 Sep; 104():154336. PubMed ID: 35849969
[TBL] [Abstract][Full Text] [Related]
5. shRNA interference of NLRP3 inflammasome alleviate ischemia reperfusion-induced myocardial damage through autophagy activation.
Meng Z; Song MY; Li CF; Zhao JQ
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):728-735. PubMed ID: 29069583
[TBL] [Abstract][Full Text] [Related]
6. QishenYiqi dripping pill protects against myocardial ischemia/reperfusion injury via suppressing excessive autophagy and NLRP3 inflammasome based on network pharmacology and experimental pharmacology.
Li M; Wang Y; Qi Z; Yuan Z; Lv S; Zheng Y; Yan Z; Wang M; Fu H; Fan X; Ji N; Liu M; Fang Z
Front Pharmacol; 2022; 13():981206. PubMed ID: 36164369
[No Abstract] [Full Text] [Related]
7. Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes.
Qiu Z; He Y; Ming H; Lei S; Leng Y; Xia ZY
J Diabetes Res; 2019; 2019():8151836. PubMed ID: 30911553
[TBL] [Abstract][Full Text] [Related]
8. Puerarin protects against myocardial ischemia/reperfusion injury by inhibiting inflammation and the NLRP3 inflammasome: The role of the SIRT1/NF-κB pathway.
Wang ZK; Chen RR; Li JH; Chen JY; Li W; Niu XL; Wang FF; Wang J; Yang JX
Int Immunopharmacol; 2020 Dec; 89(Pt B):107086. PubMed ID: 33068868
[TBL] [Abstract][Full Text] [Related]
9. TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury.
Liu Y; Lian K; Zhang L; Wang R; Yi F; Gao C; Xin C; Zhu D; Li Y; Yan W; Xiong L; Gao E; Wang H; Tao L
Basic Res Cardiol; 2014; 109(5):415. PubMed ID: 25015733
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective activity of ethyl acetate extract of Cinnamomi Ramulus against myocardial ischemia/reperfusion injury in rats via inhibiting NLRP3 inflammasome activation and pyroptosis.
Peng L; Lei Z; Rao Z; Yang R; Zheng L; Fan Y; Luan F; Zeng N
Phytomedicine; 2021 Dec; 93():153798. PubMed ID: 34673348
[TBL] [Abstract][Full Text] [Related]
11. Oridonin Attenuates Myocardial Ischemia/Reperfusion Injury via Downregulating Oxidative Stress and NLRP3 Inflammasome Pathway in Mice.
Lu C; Chen C; Chen A; Wu Y; Wen J; Huang F; Zeng Z
Evid Based Complement Alternat Med; 2020; 2020():7395187. PubMed ID: 32565873
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol pretreatment protects rat hearts from ischemia/reperfusion injury partly via a NALP3 inflammasome pathway.
Dong W; Yang R; Yang J; Yang J; Ding J; Wu H; Zhang J
Int J Clin Exp Pathol; 2015; 8(8):8731-41. PubMed ID: 26464617
[TBL] [Abstract][Full Text] [Related]
13. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.
Zhang J; Huang L; Shi X; Yang L; Hua F; Ma J; Zhu W; Liu X; Xuan R; Shen Y; Liu J; Lai X; Yu P
Aging (Albany NY); 2020 Nov; 12(23):24270-24287. PubMed ID: 33232283
[TBL] [Abstract][Full Text] [Related]
14. [Knockout of PTEN improves cardiac function and inhibits NLRP3-mediated cardiomyocyte pyroptosis in rats with myocardial ischemia-reperfusion].
Cui Q; Wang J; Liu X; Wang X; Su G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Mar; 36(3):205-211. PubMed ID: 32389167
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of GSK-3β alleviates cerebral ischemia/reperfusion injury in rats by suppressing NLRP3 inflammasome activation through autophagy.
Wang Y; Meng C; Zhang J; Wu J; Zhao J
Int Immunopharmacol; 2019 Mar; 68():234-241. PubMed ID: 30703695
[TBL] [Abstract][Full Text] [Related]
16. The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE
Leng W; Ouyang X; Lei X; Wu M; Chen L; Wu Q; Deng W; Liang Z
Mediators Inflamm; 2016; 2016():6305735. PubMed ID: 28104929
[No Abstract] [Full Text] [Related]
17. Iguratimod Alleviates Myocardial Ischemia/Reperfusion Injury Through Inhibiting Inflammatory Response Induced by Cardiac Fibroblast Pyroptosis via COX2/NLRP3 Signaling Pathway.
Zhang M; Lei YS; Meng XW; Liu HY; Li LG; Zhang J; Zhang JX; Tao WH; Peng K; Lin J; Ji FH
Front Cell Dev Biol; 2021; 9():746317. PubMed ID: 34760889
[No Abstract] [Full Text] [Related]
18. Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy.
Arow M; Waldman M; Yadin D; Nudelman V; Shainberg A; Abraham NG; Freimark D; Kornowski R; Aravot D; Hochhauser E; Arad M
Cardiovasc Diabetol; 2020 Jan; 19(1):7. PubMed ID: 31924211
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-495 Ameliorates Cardiac Microvascular Endothelial Cell Injury and Inflammatory Reaction by Suppressing the NLRP3 Inflammasome Signaling Pathway.
Zhou T; Xiang DK; Li SN; Yang LH; Gao LF; Feng C
Cell Physiol Biochem; 2018; 49(2):798-815. PubMed ID: 30165354
[TBL] [Abstract][Full Text] [Related]
20. miR-330-5p inhibits NLRP3 inflammasome-mediated myocardial ischaemia-reperfusion injury by targeting TIM3.
Zuo W; Tian R; Chen Q; Wang L; Gu Q; Zhao H; Huang C; Liu Y; Li J; Yang X; Xu L; Zhang B; Liu Z
Cardiovasc Drugs Ther; 2021 Aug; 35(4):691-705. PubMed ID: 33137205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
